BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18379939)

  • 21. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
    Itty S; Olson JH; O'Connell DJ; Pulido JS
    Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
    Reddy R; Kim SJ
    Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate.
    de Smet MD
    Bull Soc Belge Ophtalmol; 2001; (279):91-5. PubMed ID: 11344720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular levels of methotrexate after intravenous administration.
    de Smet MD; Stark-Vancs V; Kohler DR; Smith J; Wittes R; Nussenblatt RB
    Am J Ophthalmol; 1996 Apr; 121(4):442-4. PubMed ID: 8604740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INTRAVITREAL METHOTREXATE FOR MANTLE CELL LYMPHOMA INFILTRATION OF THE OPTIC NERVES: A CASE REPORT.
    Singer JR; Nigalye AK; Champion MT; Welch MJ
    Retin Cases Brief Rep; 2018 Winter; 12(1):5-9. PubMed ID: 27529778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravitreal chemotherapy for intraocular lymphoma].
    Helbig H; Cerny T; de Smet MD
    Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of kinetics of methotrexate for therapeutic treatment of intraocular lymphoma.
    Palakurthi NK; Krishnamoorthy M; Augsburger JJ; Correa ZM; Banerjee RK
    Curr Eye Res; 2010 Dec; 35(12):1105-15. PubMed ID: 20961217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectral-domain Optical Coherence Tomography Patterns in Intraocular Lymphoma.
    Keino H; Okada AA; Watanabe T; Echizen N; Inoue M; Takayama N; Nagane M
    Ocul Immunol Inflamm; 2016 Jun; 24(3):268-73. PubMed ID: 25760916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal therapy of primary ocular lymphoma.
    Plowman PN; Taylor A; Jackson AS; Lightman S; Pavesio C
    Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):521. PubMed ID: 12512978
    [No Abstract]   [Full Text] [Related]  

  • 30. Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal Lymphoma With Methotrexate.
    Gu J; Jiang T; Liu S; Chen X; Wang Z; Zhang P; Wang L; Jiang R; Huang X; Xu G; Chang Q
    Am J Ophthalmol; 2023 Jul; 251():189-196. PubMed ID: 36963600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma.
    Mohammad M; Andrews RM; Plowman PN; Hay G; Arora AK; Cohen VML; Sagoo MS
    Br J Ophthalmol; 2022 Jan; 106(1):135-140. PubMed ID: 33087316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.
    Corona G; Giannini F; Fabris M; Toffoli G; Boiocchi M
    Int J Cancer; 1998 Jan; 75(1):125-33. PubMed ID: 9426700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.
    Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A
    Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraocular use of rituximab.
    Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
    Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary intraocular lymphoma].
    Coupland SE; Heimann H
    Ophthalmologe; 2004 Jan; 101(1):87-98. PubMed ID: 14986704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    Spinella MJ; Brigle KE; Sierra EE; Goldman ID
    J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular Manifestations of Leukemia and Results of Treatment with Intravitreal Methotrexate.
    Vishnevskia-Dai V; Sella King S; Lekach R; Fabian ID; Zloto O
    Sci Rep; 2020 Feb; 10(1):1994. PubMed ID: 32029770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination treatment of intraocular lymphoma.
    Valluri S; Moorthy RS; Khan A; Rao NA
    Retina; 1995; 15(2):125-9. PubMed ID: 7624599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cell lines with a defective reduced folate carrier.
    Brigle KE; Seither RL; Westin EH; Goldman ID
    J Biol Chem; 1994 Feb; 269(6):4267-72. PubMed ID: 8307991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
    Kvopka M; Lake SR; Smith JR
    Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.